Retrospective Cohort Study
Copyright ©The Author(s) 2019.
World J Gastrointest Oncol. Jul 15, 2019; 11(7): 538-550
Published online Jul 15, 2019. doi: 10.4251/wjgo.v11.i7.538
Table 1 Patient-related variable
VariableIntraoperative chemotherapy (+) (n = 171)Intraoperative chemotherapy(-) (n = 306)P-value
Age (yr, mean ± SD)58.1 ± 10.159.1 ± 11.30.627
Sex, n (%)0.829
Male109 (63.7)192 (62.7)
Female62 (36.3)114 (37.3)
BMI (kg/m2, mean ± SD)24.4 ± 3.123.9 ± 3.40.123
Smoking, n (%)59 (34.5)87 (28.4)0.168
Alcohol, n (%)46 (26.9)67 (21.9)0.218
Hypertension, n (%)46 (26.9)75 (24.5)0.565
Ischemic heart disease, n (%)6 (3.5)7 (2.3)0.622
Diabetes, n (%)22 (12.9)39 (12.7)0.970
Hepatitis, n (%)14 (8.2)16 (5.2)0.202
History of malignancy, n (%)9 (5.3)12 (3.9)0.493
Incomplete intestinal obstruction, n (%)20 (11.7)25 (8.2)0.206
Preoperative chemotherapy, n (%)32 (18.7)65 (21.2)0.511
Preoperative radiotherapy, n (%)21 (12.3)44 (14.4)0.522
Preoperative hemoglobin, (g/L, mean ± SD)136.8 ± 18.1136.2 ± 18.00.813
Preoperative albumin (g/L, mean ± SD)43.6 ± 3.544.2 ± 3.70.075
ASA grade, n (%)0.987
16 (3.5)14 (4.6)
2154 (90.1)269 (87.9)
311 (6.4)23 (7.5)